Georgy Egorov is Chief Financial Officer of Vaccitech, a firm that develops vaccines and T cell immunotherapies to treat and prevent cancer and infectious diseases. It was one of the firms behind the recently launched Oxford/AstraZeneca Covid-19 vaccine. He has held a series of executive roles in fintech and biotech firms, and prior to that worked in finance both at the EBRD and investment banking.

An inspiring story of coming out in Russia in the 1990s, the changing experience of LGBT inclusion in investment banking and why the flat structure of biotech offers such a different set of opportunities not just for professional growth but also for inclusion.